SD-101 and Keytruda Combo Fights Head and Neck Tumors, Trial Shows
News
A combination of Dynavax Technologies’ immunotherapy SD-101 and Keytruda triggered tumor-fighting responses in a third of patients with an advanced head and neck cancer, a Phase 1b/2 clinical trial showed. The response rate was double the 15 ... Read more